The Immunology of Acne

  • Guy F. Webster
  • Jenny Kim
  • Acne is a complex disease with multiple pathogenic factors.

  • Propionibacterium acnes is the trigger for inflammatory acne.

  • There is no suitable animal model for acne.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kligman AM. An overview of acne. J Invest Dermatol 1974;62:268–287.PubMedCrossRefGoogle Scholar
  2. 2.
    McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. Regional variations of cutaneous propionibacte-ria, correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1980;12:672–675.PubMedGoogle Scholar
  3. 3.
    Webster GF, Ruggieri MR, McGinley KJ. Correlation of Propionibacterium acnes populations with the presence of triglycerides on non-human skin. Appl Environ Microbiol 1981;41:1269–1270.PubMedGoogle Scholar
  4. 4.
    Webster GF. Acne. Curr Prob Dermatol 1996;8: 240–262.Google Scholar
  5. 5.
    Marples RR, McGinley KJ. Corynebacterium acnes and other anaerobic diphtheroids from human skin. J Med Microbiol 1974;7:349–61.PubMedGoogle Scholar
  6. 6.
    Puhvel SM, Sakamoto M, Cytotaxin production by comedonal bacteria. J Invest Dermatol 1978;71: 324–329.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee WL, Shalita AR, Sunthralingam K. Neutrophil chemotaxis to P. acnes lipase and its inhibition. Infect Immun 1982;35:71–78.PubMedGoogle Scholar
  8. 8.
    Webster GF, Leyden JJ, Tsai C-C. Characterization of serum independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980;4:261–271.PubMedCrossRefGoogle Scholar
  9. 9.
    Allaker RP, Greenman J, Osborne RH. The production of inflammatory compounds by Propionibacterium acnes and other skin organisms. Br J Dermatol 1987;117(2):175–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Hellgren L, Vincent J. New group of prostaglan-din-like compounds in P. acnes. Gen Pharmacol 1983;14(1):207–8.PubMedGoogle Scholar
  11. 11.
    Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alphalike bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992;98(6):895–901.PubMedCrossRefGoogle Scholar
  12. 12.
    Webster GF, Leyden JJ, Tsai CC, Baehni P, McArthur WP. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol 1980;74(6):398–401.PubMedCrossRefGoogle Scholar
  13. 13.
    Webster GF, Nilsson UR, McArthur WR, Activation of the alternative pathway of complement by Propionibacterium acnes cell fractions. Inflammation 1981;5:165–176.PubMedCrossRefGoogle Scholar
  14. 14.
    Webster GF, McArthur WR. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate. J Invest Dermatol 1982;79:137–140.PubMedCrossRefGoogle Scholar
  15. 15.
    Webster GF, Leyden JJ, Musson RA, Douglas SD. Susceptibility of Propionibacterium acnes to killing and degradation by human monocytes and neu-trophils in vitro. Infect Immun 1985;49:116–121.PubMedGoogle Scholar
  16. 16.
    Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995;63:3158–3165.PubMedGoogle Scholar
  17. 17.
    Suzuki S, Duncan GS, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002;416:750–756.PubMedCrossRefGoogle Scholar
  18. 18.
    Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335–376.PubMedCrossRefGoogle Scholar
  19. 19.
    Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085– 2088.PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshimura A, Lien E, Ingalls RR, et al. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll—like receptor 2. J Immunol 1999;163:1–5.PubMedGoogle Scholar
  21. 21.
    Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll—like receptor 5. Nature 2001;410:1099–1103.PubMedCrossRefGoogle Scholar
  22. 22.
    Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor that recognizes bacterial DNA. Nature 2000;408:740–745.PubMedCrossRefGoogle Scholar
  23. 23.
    Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732–738.PubMedCrossRefGoogle Scholar
  24. 24.
    Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88—dependent signaling pathway. Nature Immunol 2002;3:196–200.CrossRefGoogle Scholar
  25. 25.
    Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169:1535–1541.PubMedGoogle Scholar
  26. 26.
    Trivedi NR, Gilliland KL, Zhao W, et al. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 2006;126:1071–1079.PubMedCrossRefGoogle Scholar
  27. 27.
    Kang S, Chung JH, Hammerberg C, et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005;166:1691–1699.PubMedGoogle Scholar
  28. 28.
    Philpott MP. Defensins and acne. Mol Immunol 2003;40:457–462.PubMedCrossRefGoogle Scholar
  29. 29.
    Scott MG, Davidson DJ, Gold MR, et al. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002;169:3883–3891.PubMedGoogle Scholar
  30. 30.
    Phan J, Liu P Krutzik SR, et al. Propionibacterium acnes differentiates monocytes into CD209—2B; mono-cytes and CD1b+ dendritic cells. J Invest Dermatol 2006;126:124.Google Scholar
  31. 31.
    Liu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR, Kim J. CD209(+) macrophages mediate host defense against Propionibacterium aches. J Immunol 2008;180(7):4919–23.PubMedGoogle Scholar
  32. 32.
    Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33(2 pt 1):247–53.CrossRefGoogle Scholar
  33. 33.
    Webster GF, Kligman AM. A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol 1979;73(4):266–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Tosti A, Guerra L, Bettoli V, et al. Solid facial edema as a complication of acne in twins. J Am Acad Dermatol 1987;17:843–844.PubMedCrossRefGoogle Scholar
  35. 35.
    Fitzsimmins JS, Guilbert PR. A family study of hid-radinitis suppurativa. J Med Gen 1985;22:367–373.Google Scholar
  36. 36.
    Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet 1984;21(4):281–5.PubMedGoogle Scholar
  37. 37.
    Quintal D, Jackson R. Aggressive squamous cell carcinoma arising in familial acne conglobata. J Am Acad Dermatol 1986;14:207–214.PubMedCrossRefGoogle Scholar
  38. 38.
    Webster GF, Leyden JJ, Norman ME, Nilsson UR. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 1978;22(2):523–9.PubMedGoogle Scholar
  39. 39.
    Webster GF, Indrisano JP, Leyden JJ. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Dermatol 1985;84(6):496–500.PubMedCrossRefGoogle Scholar
  40. 40.
    Puhvel SM, Hoffman IK, Sternberg TH. Corynebacterium acnes. Presence of complement fixing antibodies to Corynebacterium acnes in the sera of patients with acne vulgaris. Arch Dermatol 1966;93(3):364–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Puhvel SM, Barfatani M, Warnick M, Sternberg TH. Study of antibody levels to C. acnes in the serum of acne patients. Arch Dermatol 1964;90:421–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Ashbee HR, Muir SR, Cunliffe WJ, Ingham E. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Br J Dermatol 1997;136(5):730–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Ingham E, Gowland G, Ward RM, Holland KT, Cunliffe WJ. Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris. Br J Dermatol 1987;116(6):805–12.PubMedCrossRefGoogle Scholar
  44. 44.
    Puhvel SM, Amirian D, Weintraub J, Reisner RM. Lymphocyte transformation in subjects with nodulocystic acne. Br J Dermatol 1977;97(2): 205–11.PubMedCrossRefGoogle Scholar
  45. 45.
    Puhvel SM, Hoffman IK, Reisner RM, Sternberg TH. Dermal hypersensitivity of patients with acne vul-garis to Corynebacterium acnes. J Invest Dermatol 1967;49(2):154–8.PubMedGoogle Scholar
  46. 46.
    Wilcox HE, Farrar MD, Cunliffe WJ, Holland KT, Ingham E. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes. Br J Dermatol 2007;156(3):460–5PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2008

Authors and Affiliations

  • Guy F. Webster
    • 1
  • Jenny Kim
    • 2
  1. 1.Jefferson Dermatology AssociatesPhiladelphiaUSA
  2. 2.Department of DermatologyUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations